Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the issues in chronic obstructive lung disease.

Jean Berry1

  • 1University of Illinois College of Nursing, 845 S. Damen Avenue, Chicago, IL 60612, USA. jkberry@uic.edu

Expert Opinion on Emerging Drugs
|November 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

σ<sub>1</sub> receptor agonists: the new trend or an emerging therapeutic option?

Expert opinion on emerging drugs·2026
Same journal

Obefazimod (ABX464) for moderate-to-severe Crohn's disease: clinical development of a novel oral therapeutic approach.

Expert opinion on emerging drugs·2026
Same journal

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease.

Expert opinion on emerging drugs·2026
Same journal

Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond.

Expert opinion on emerging drugs·2026
Same journal

Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies.

Expert opinion on emerging drugs·2026
Same journal

Acute management of adult MOG antibody-associated disease: therapeutic choices and clinical outcomes.

Expert opinion on emerging drugs·2026

Chronic obstructive pulmonary disease (COPD) research is increasing, focusing on cellular mechanisms and inflammation distinct from asthma. New therapeutic targets are emerging from studies on inflammatory mediators, oxidative stress, and genetics.

Area of Science:

  • Pulmonology
  • Cellular Biology
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) has an unclear cause and variable pathology.
  • Current treatments primarily manage symptoms rather than underlying disease mechanisms.
  • Research into COPD's cellular mechanisms and distinct inflammatory processes is accelerating.

Purpose of the Study:

  • To explore the cellular mechanisms underlying COPD.
  • To identify new therapeutic targets for COPD pharmacotherapy.
  • To differentiate COPD's inflammatory profile from asthma.

Main Methods:

  • Review of current research on COPD etiology and pathology.
  • Analysis of inflammatory mediators and oxidative stress in COPD.
  • Investigation of protease-antiprotease balance and molecular genetics.

Related Experiment Videos

Main Results:

  • Focus shifting from symptom management to disease mechanisms.
  • Identification of specific inflammatory mediators and oxidative stress roles.
  • Emerging understanding of protease-antiprotease imbalance and genetic factors.

Conclusions:

  • New pharmacotherapy targets are being identified for COPD.
  • Understanding cellular mechanisms and inflammation is key to novel treatments.
  • Molecular genetics offers future avenues for COPD drug development.